Articles tagged with Depression
A study from Duke University found that a weight management program significantly reduced depression in nearly half of low-income black women. The 12-month intervention included personalized goals and behavioral changes, which had no direct impact on weight loss or treatment for depression.
Chinese researchers discovered that people with major depressive disorder have impaired self-face recognition, including increased self-focus and sensitivity to the self-face. This impairment cannot be attributed to medication status and suggests that depression is associated with abnormal self-bias.
Research suggests that impaired inhibition of medium spiny neurons in the nucleus accumbens contributes to childhood depression. The study found that nomifensine can alleviate depressive behaviors by reducing neuron membrane excitability.
A study by The Miriam Hospital found that women with Chronic Obstructive Pulmonary Disease (COPD) who are also depressed have difficulty sticking to a pulmonary rehabilitation program. Lower depressed mood independently predicted finishing PR for women, but not men.
A new study led by Dr. Barry Rovner shows that a type of rehabilitation therapy can cut the risk of depression from age-related macular degeneration (AMD) in half. The therapy, called behavior activation, helps people focus on activities they enjoy and maintain an active social life to reduce disability and prevent clinical depression.
A clinical trial shows that integrated low vision and mental health treatment can reduce depression in AMD patients by half. The approach combines behavior activation therapy with low vision occupational therapy, leading to improved functional vision and mood.
A meta-analysis of 17 clinical trials found that early filiform needle acupuncture significantly improved depression symptoms and was safer than conventional medications. This study provides evidence for the effectiveness of acupuncture in managing poststroke depression.
Researchers identified two antidepressant classes, including the alpha-2-adrenergic receptor antagonist Mianserin, that improve symptoms of depression in cancer patients. However, these treatments may be less well-tolerated due to potential side effects.
A large-scale clinical study found that adults with Asperger Syndrome are nine times more likely to experience suicidal thoughts compared to the general population. The study also revealed a significant link between depression and increased risk of suicidal ideation in this group.
A study found that when couples disagree on stroke recovery, the caregiving spouse experiences depression and emotional distress. The discrepancy in perceptions between survivors and spousal caregivers is key to predicting depression in spousal caregivers.
Researchers found that high blood glucose levels increase neurotransmitter associated with depression and alter brain connections in patients with Type 1 diabetes. The study suggests a biological mechanism for the increased risk of depression in these individuals.
Researchers at Weizmann Institute identify microRNA molecule miR135 linked to serotonin system and its role in depression and anxiety disorders. Higher levels of miR135 found in healthy mice resistant to chronic stress, while low levels associated with depressed behavior and weaker response to antidepressants.
Research at Umeå University reveals that low cortisol levels increase the risk of depression in people with bipolar disorder. The study found that both high and low cortisol levels impaired mental health, with those having low cortisol levels experiencing a chronic state of the disorder.
Researchers have identified a fast-acting compound, hydroxynorketamine (HNK), that may treat symptoms of depression just as effectively and rapidly as ketamine without unwanted side effects. HNK also shows promise in treating neurodegenerative disorders like Alzheimer's and Parkinson's diseases.
Researchers found that interventions for diabetes distress significantly reduced symptoms of depression in people with type 2 diabetes. In contrast, patients with type 1 diabetes who reported high levels of depressive symptoms had a higher mortality risk. These findings suggest that 'diabetes distress' may not be a co-morbid psychiatri...
Researchers at UT Southwestern Medical Center have found that blocking NMDA receptors with ketamine can elicit rapid antidepressant effects in patients with treatment-resistant depression. The study suggests that this fundamental difference between ketamine and memantine could lead to a new class of drugs with fewer side effects.
A new study links opioid pain relievers to less improvement and higher levels of dissatisfaction following spine surgery. Patients who used opioids before surgery had worse health outcomes at 3 and 12 months post-op, according to a study published in the Journal of Bone and Joint Surgery.
Researchers at McGill University discovered a tiny molecule, miR-1202, that regulates glutamate receptors and is lower in the brains of depressed individuals. The study found that this microRNA increases with antidepressant treatment, suggesting it could be a potential target for developing new treatments.
A recent study by CAMH found that pre-menopausal women have higher levels of a brain protein called monoamine oxidase-A (MAO-A), linked to depression. MAO-A breaks down brain chemicals that help regulate mood. The study suggests new opportunities for prevention, including dietary supplements and hormone replacement therapy.
A $26 million research project employs advanced technology to understand and treat psychiatric disorders by analyzing brain networks. The project aims to develop neural stimulation therapies to 'unlearn' detrimental signaling patterns, potentially eliminating symptoms.
A team of researchers at Cold Spring Harbor Laboratory has identified the group of neurons in the brain that determines how a mouse responds to stress, whether with resilience or defeat. The study's findings may lead to improved treatments for depression.
A new study reveals that Sardinians' active lifestyle, social connections, and access to healthcare contribute to lower levels of depression among the elderly. In contrast, residents from Northern Italy face higher rates of depression due to factors like limited social support and high-stress lifestyles.
Researchers found that a revised version of the Obsessive Beliefs Questionnaire, shortened from 87 to 20 items, can also assess symptoms of depression and anxiety. The study's findings suggest that the questionnaire may be a useful tool for understanding mental health disorders beyond OCD.
Research suggests that preschool teacher depression is associated with behavioral problems in children, including aggression, anxiety, and sadness. The study found a direct relationship between teacher depression and internalizing problems in children, as well as a lower-quality child care atmosphere.
The study found that Shuganjieyu capsule increases brain-derived neurotrophic factor and phosphorylated cyclic adenosine monophosphate response element binding protein expression levels, which may be one of the anti-depressant mechanisms. This increase in expression reverses depressive-like behaviors in rat models of depression.
Researchers found psilocybin inhibits amygdala activity, weakening negative stimuli processing and correlating with enhanced positive mood. This mechanism may lead to novel treatments for depression and anxiety disorders.
Women who received collaborative care for depression at an obstetrics and gynecology clinic showed significant reduction in symptoms, with more than half experiencing post-traumatic stress disorder as well. The approach, called Depression Attention for Women Now, improved patient engagement, treatment recommendations, and follow-up care.
A University of Alberta study found that negative emotions experienced as young adults can persistently affect couple relationships well into middle age. Recognizing the importance of early mental health is crucial to future happiness and may help prevent social costs like divorce and domestic violence.
A new analysis of data from two independent studies shows that Transcranial Magnetic Stimulation (TMS) administered with the NeuroStar TMS Therapy System resulted in greater symptom improvement than conventional antidepressant medication among patients with Major Depressive Disorder who failed to benefit from prior treatment. Additiona...
A pilot study revealed that once-monthly NeuroStar TMS maintenance therapy induced remission in 61.2% of medication-free patients with Major Depressive Disorder after 6 weeks. At three months, 62.5% of these patients maintained response compared to 43.8% without maintenance treatment.
A recent KU Leuven study reveals that suppressing positive emotions plays a significant role in the development of postpartum depression. The study found that women who downplayed or suppressed happy feelings were more likely to experience depressive symptoms postpartum.
A new study using MRI analysis found that patients who responded to subcallosal cingulate (SCC) deep brain stimulation showed a common pattern of three distinct white matter bundles passing through the SCC. Non-responders did not show this pattern, suggesting that precise mapping is crucial for successful treatment.
A recent study by University of Wisconsin-Madison researchers found that chronic marital stress can make people more vulnerable to depression. Participants who reported higher marital stress had shorter-lived responses to positive images than those reporting more satisfaction in their unions.
A Vanderbilt study found that two-thirds of ICU patients experience somatic symptoms like weakness, appetite change, and fatigue, surpassing cognitive symptoms. The study highlights a significant public health issue, with millions of patients admitted to ICUs annually.
Researchers have identified a new mechanism by which ghrelin works to limit depression, as well as a potentially powerful neuroprotective drug called P7C3 that may provide greater anti-depressant effects.
A study published in Psychiatry Research found that dopamine replacement therapy commonly used to treat motor symptoms of Parkinson's disease was associated with a decline in cognitive performance among depressed Parkinson patients. Mood in depressed Parkinson's patients was also worse while on dopaminergic medications.
A study published by the American Academy of Neurology found that people with apathy symptoms have smaller brain volumes than those without apathy. Apathy is a lack of interest or emotion, and the findings suggest it may be an indicator of accelerated brain aging.
A telephone-based collaborative care model was effective in managing depression and anxiety in patients with heart disease, improving health-related quality of life. The study found that patients receiving the intervention had greater average improvement in mental health scores at 24 weeks compared to those in the control group.
Saint Louis University researcher Jeffrey Scherrer is investigating the link between chronic opioid use and depression risk. He will analyze medical records of 1 million patients, including those with VA and private sector prescriptions, to understand the impact of opioid exposure on mental health.
The UCLA/RAND community research team won a prestigious award for their 10-year effort to improve depression care in low-income areas. The team's collaborative approach showed that community engagement can provide measurable added value, leading to improved mental and physical health outcomes.
A study published in Biological Psychiatry found that intranasal ketamine conferred an unusually rapid antidepressant effect within 24 hours and was well-tolerated in patients with treatment-resistant major depressive disorder. The results show promise for a new treatment class, targeting the NMDA glutamate receptor.
Residents of poorer Chicago neighborhoods face more life-changing negative events and experience a range of serious health issues due to the complex interplay between traumatic events and lack of resources. The study's findings highlight the need for addressing poverty and providing support for vulnerable populations.
A third of ICU survivors develop depression manifesting as physical symptoms, such as weakness and fatigue, rather than psychological symptoms. Depression is four times more common than PTSD after critical illness, highlighting the need for new treatment approaches focusing on physical rehabilitation.
A study of nearly 63,000 Norwegians found that moderate to severe depression increases the risk of heart failure by 40%. Depression triggers stress hormones and inflammation, which may accelerate heart diseases. Early detection and treatment can help improve outcomes.
Researchers at Oxford Health NHS Foundation Trust and the University of Oxford conducted a UK study on the use of ketamine intravenous infusions in people with treatment-resistant depression. The study found that 29% of patients experienced benefit that lasted at least three weeks, while 15% took over 2 months to relapse.
A new study published in the Journal of Psychiatric Research found that patients injected with Botox showed substantial improvement in their depressive symptoms. The study included 74 depressed subjects who received either Botox or a placebo and showed a 47% decrease in depressive symptoms after six weeks.
Depression patients showed characteristic path length and node attributes differences compared to healthy controls. An artificial neural network algorithm demonstrated the effectiveness of brain network metrics in machine learning research and clinical diagnosis of depression.
A systematic review and meta-analysis of published studies on antidepressants in pregnancy found a strong association between their use and increased preterm birth rates. The study suggests that antidepressant medications may be contributing to the rising trend of preterm births, which can lead to significant health problems and costs.
Researchers found that acupuncture/electroacupuncture combined with Seroxat improves depressive symptoms and reduces obsessive-compulsive and anxiety symptoms. The treatment produces a rapid onset of therapeutic effect.
Researchers found that galanin plays a crucial role in stress mechanisms and influences depression risk, particularly in those with early life neglect or trauma. A new class of antidepressant drugs targeting galanin functionality may provide effective treatment options for patients.
A new five-year study aims to determine whether treating depression in patients with heart failure can help them live longer. The Hopeful Heart trial will include 750 participants who meet severity criteria for heart failure and screen positive for depression.
Researchers at CAMH have developed a nasal spray that delivers a peptide to treat depression, providing an alternative therapeutic approach. The peptide treatment interferes with dopamine receptors, leading to anti-depressant effects and showing potential in relieving symptoms.
A new study by Rutgers University–Camden professor Naomi Marmorstein found that depression in early adolescence predicts obesity in late adolescence among female participants. Conversely, obesity in late adolescence predicts the onset of depression in early adulthood. The study suggests a reciprocal relationship between the two disorde...
Researchers found that problem-solving therapy and dietary coaching were equally effective in preventing major depression among older adults. The study's findings suggest that lifestyle interventions can have a positive effect on well-being and protect against the onset of depression.
A recent study found that active, older caregivers who continue to engage in hobbies and activities are happier after caring for a loved one with a stroke. These caregivers were also better physically healthy and provided higher levels of assistance to the stroke survivor.
Patients who joined a social group and developed a stronger connection with its members experienced reduced symptoms of depression. The study suggests that the 'group' aspect of social interaction is critical in alleviating depression.
A recent systematic review of clinical trials found that vitamin D supplementation had little to no effect on depression. However, additional analyses suggested that vitamin D supplements may help patients with clinically significant depression when combined with traditional antidepressant medication.
Researchers at the University of Montreal found that increased psychological distress and depression symptoms are associated with high cortisol levels, while severe burnout is linked to low cortisol concentrations. This study aims to develop more accurate screening tools for mental health professionals.
A study by Massachusetts General Hospital found that cognitive behavioral therapy addressing mood and treatment management skills improved blood sugar control and reduced depression symptoms in poorly-controlled type 2 diabetes patients. The integrated approach showed faster relief of depression symptoms compared to usual care.
A review of scientific literature indicates that depression should be added to the list of risk factors associated with heart disease. Studies found that depression increases the likelihood of having a heart attack or dying from heart disease.